“Committed to Excellence in Life Sciences Executive Search”
The Chase Group completes CMO search with Akcea Therapeutics
The Chase Group is proud to announce the completion of the Chief Medical Officer search with Akcea Therapeutics. The CMO will provide innovative and visionary leadership to develop clinical and medical strategy for a pipeline that has the potential to change the approach to treating cardiometabolic lipid disorders. To learn more about The Chase Group’s strength in securing senior leadership talent, contact us at chase@chasegroup.com.
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience….
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD as the Vice President, Pulmonary and Rare Diseases Clinical Development…
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually…
The Chase Group, known for its thorough search capabilities and expertise in Life Sciences Executive Search, was retained by Genmab Pharmaceuticals to execute a critical…
Building on a 14+ year relationship with Chase, the Chief Medical Officer of Checkmate Pharmaceuticals retained The Chase Group to identify a critical hire for…
The Chase Group was once again retained by Akcea Therapeutics to complete an extensive executive search on an accelerated timeline for a Senior Vice President,…